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Abstract 
Individuals in substance use (SU) disorder treatment are attempting to maintain abstinence, but 
the positive rewards associated with abstinence are uncertain. Understanding how individuals 
weigh reward probability (RP) and reward magnitude (RM) in decision making is salient for 
understanding the factors associated with continued abstinence. This study sought to test 
associations between effort expenditure for reward and SU outcomes among individuals entering 
outpatient SU treatment, and if SU moderates relationships between effort expenditure from pre-
treatment to 3-month follow-up. Participants (N=86) completed the Effort Expenditure for 
Rewards Task (EEfRT) and the Timeline Followback (TLFB) at baseline and 3-month follow-up 
assessments. The independent variables in both primary and moderation analyses were 
proportion of hard choices for low and medium probability of reward. The primary DV was 
percent of days of any SU at 3-month follow-up, and the DV in moderation analyses was 
proportion of hard choices on the EEfRT at 3-month follow-up for low and medium probability 
of reward. Results of hierarchical linear regressions yielded no significant relationships between 
percent of hard choices at any level of reward probability at baseline and SU frequency at 3-
month follow-up. Likewise, the association between effort expenditure for reward at baseline and 
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Willingness to Expend Effort for Reward and Substance Use Outcomes in Treatment 
Every year, an estimated 740 billion dollars are lost to substance use disorder [SUD] in 
the United States and more than 90,000 American deaths are linked to alcohol and drug use [U.S. 
National Institute on Drug Abuse (NIDA), 2017] . In 2015, it was estimated that 21.5 million 
people aged 12 or older qualified for SUD in the United States (Lipari & Van Horn, 2017). The 
scope of this problem highlights an important area of need for furthering dissecting factors that 
contribute to the development and maintenance of SUD to alleviate this public health crisis. One 
major factor known to be associated with SUD is the dysregulation of the natural reward 
processing systems of the brain (Kelley & Berridge, 2002). However, detailed information on 
certain aspects of reward processing, such as how individuals suffering from SUD weigh 
likelihood of receiving rewards with the potential benefits or magnitude of said rewards in 
decision making is still unclear. Further understanding of how various aspects of reward are 
related to decision making in SUD could generate greater understanding of the development and 
maintenance of SUD, which in turn could aid in interventions aiming to prevent SUD from 
occurring or aid in treatment for SUD. The goal of this study is to test the relationship between 
effortful decision making for uncertain reward and substance use among individuals with SUD. 
Reward Dysregulation and Substance Use 
SUD has been shown to be associated with a dysregulation of the reward processing 
system of the brain (Koob & Le Moal, 2001). This dysregulation in the reward processing 
system is thought to happen through three (un-exclusive) ways: activation of natural reward 
systems already present in the brain for evolutionarily advantageous behaviors such as eating, a 
distortion of normal reward processes such that rewards are differentially weighted in value in 
the mind, and/or the introduction of unfamiliar processes in the brain only associated with drug 
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use, for instance, stronger aversive-withdrawal states than those associated with natural rewards 
(Kelley & Berridge, 2002).  
Substance use behavior is thought to be strongly influenced by the positive rewards that 
are associated with use (Kelley & Berridge, 2002). Additionally, aversive states such as 
withdrawal are thought to serve as motivators for substance use through moderating the strength 
of incentives to seek the reward associated with using said substance (Kelley & Berridge, 2002). 
Differences in reward processing within the population of individuals who suffer from SUD  
have been shown to be predictive of abstinence at follow-up (Gowin, Ball, Wittmann, Tapert, & 
Paulus, 2015).  
Theories that reward processing is dysregulated in those who suffer from SUD are 
supported by findings from imaging studies in which chronic substance use has been shown to be 
related to alterations in frontal lobe volume (Schlaepfer et al., 2006; Wang et al., 2012). The 
frontal cortex is associated with decision-making and reward processing (Kennerley & Walton, 
2011), which serves to support arguments that reward processing becomes dysregulated through 
physiological, in addition to psychological changes. Additionally, neural activity has been shown 
to differ significantly between individuals with substance use disorder and healthy controls on 
reward processing tasks with substance and monetary related reward cues (García-García et al., 
2014). 
Dysregulated Decision-Making in Substance Use Disorder 
The use of alcohol and illicit substances is associated with immediate positive 
neurochemical rewards (Adinoff, 2004), but negative long-term outcomes. Therefore, the choice 
to consistently pursue use is theorized to be related to inefficient decision making, which is 
thought to develop through three stages: preference development through valuation of decision 
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making consequences, implementation of choices that involve motivation, inhibitory processes 
and self-regulation, and the processing of feedback that leads to learning associated with 
reinforcement of substance use (Verdejo-Garcia, Chong, Stout, Yücel, & London, 2018). The 
altered reward system associated with SUD has been shown to be related to differential levels of 
risk taking decisions in response to varying dimensions of probability and value of reward (Voon 
et al., 2015), as well as a larger propensity to choose superficially attractive rewards in decision 
making tasks (Verdejo-Garcia et al., 2018).  
Effort Expenditure for Reward Task 
Within the last 10 years, a new measure has emerged through which to measure 
willingness to expend effort for reward: the Effort Expenditure for Rewards Task (Treadway, 
Buckholtz, Schwartzman, Lambert, & Zald, 2009), or EEfRT, which quantifies the willingness to 
put forth effort to receive differing levels of reward while weighing changing probabilities of 
receiving said rewards in decision making. The measure was designed to be an objective 
measure of anhedonia, or decreased sensitivity and motivation to seek reward (Treadway et al., 
2009). Importantly, while several measures had previously quantified sensitivity to positive 
stimuli and responsiveness to reward cues associated with reward probability in individuals 
experiencing anhedonia, no behavioral measure until the EEfRT quantified the multiple factors 
(e.g. likelihood of receiving reward, amount of reward, effort needed to receive the reward, etc.) 
that interact to predict the decision to seek reward (Treadway et al., 2009).  
Since the design of the EEfRT, the measure has been used to quantify the interacting 
aspects of decision-making behavior related to reward in populations with psychiatric diagnoses 
that are hypothesized to suffer from reward dysregulation. For example, individuals with 
schizophrenia have been shown to differ when compared to healthy controls in their ability to 
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maximize reward on the EEfRT task (McCarthy, Treadway, Bennett, & Blanchard, 2016; 
Treadway, Peterman, Zald, & Park, 2014). Additionally, extreme ambitions in those 
experiencing bipolar disorder have also been linked to effortful decision making as measured by 
the EEfRT (Hershenberg et al., 2016). 
Additionally, studies utilizing populations with disorders with similar reward processing 
dysregulation to SUD, such as the obese population (García-García et al., 2014), have linked 
obesity to lowered willingness to expend effort for reward (Mathar, Horstmann, Pleger, 
Villringer, & Neumann, 2016) and have established a link between greater adherence to weight-
loss treatment and willingness to expend effort for an uncertain reward (Mata et al., 2017).  
Effort Expenditure for Reward and Substance Use Disorder 
It is proposed that the dysregulated reward system of those with a SUD is related to 
lowered sensitivity and motivation to seek out natural rewards (Volkow et al., 2010). 
Additionally, differences in neural activation for riskier, greater reward magnitudes has been 
shown to be associated with abstinence at follow-up (Gowin et al., 2015). The aforementioned 
study utilized the Risky Gains Task (Paulus, Rogalsky, Simmons, Feinstein, & Stein, 2003), 
which presents participants with multiple trials in which they are able to either earn high reward 
in a high risk scenario or are also presented with a “safer”, low risk low reward option for task 
completion. While relationships between the RGT and abstinence highlight decision making in 
scenarios involving varying reward probability and reward magnitude as an area of focus, the 
task does not vary in difficulty to achieve the reward (Paulus et al., 2003). The EEfRT is able to 
quantify responses to both reward magnitude and reward probability when making decisions 
associated with varying levels of difficulty (Treadway et al., 2009). Using the EEfRT to predict 
abstinence would further expand upon factors associated with reward processing.  
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 The EEfRT was originally designed to quantify how anhedonia is associated with 
various aspects of decision making when seeking reward, and those experiencing anhedonia have 
demonstrated reduced willingness to expend effort for reward (Bryant, Winer, Salem, & Nadorff, 
2017; Treadway et al., 2009). Anhedonia has previously been shown to be related to SUD 
diagnosis (Garfield, Lubman, & Yücel, 2014), highlighting the consequences of anhedonia for 
those who are suffering from SUD and the potential for altered effortful decision making when 
contemplating varying reward probabilities and magnitudes. 
Since the EEfRT was designed within the last 10 years, there are very few studies 
evaluating effort-expenditure for reward among individuals with a SUD.  Two studies thus far 
have used the EEfRT within the population of individuals who use substances (Lawn et al., 
2016; Rubenis, Fitzpatrick, Lubman, & Verdejo-Garcia, 2018). The first of these studies 
demonstrated that using cannabis is related to lower effort expenditure for reward on the EEfRT 
task when compared to participants who were given a placebo (Lawn et al., 2016), highlighting 
at least temporary influences of substance use on effortful decision making for reward. The 
second, more recent study, examined relationships between the EEfRT and changes in treatment 
motivation, and found no significant associations between the two (Rubenis et al., 2018). 
However, this study was limited to methamphetamine users, rather than a larger more diverse 
range of individuals who suffer from SUD and the study lost 31% of their participants to 
attrition, which could theoretically have had significantly less motivation to attend treatment than 
those who remained in the study. Further research is needed to understand how effort 
expenditure for reward is related to substance use and treatment outcomes.   
Known Factors Associated with Substance Use Treatment Outcomes 
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Several factors have been consistently shown to be related to substance use outcomes 
(e.g. abstinence, relapse, meeting criteria for SUD) including sex, comorbid psychiatric disorders 
including anxiety, depression, anti-social personality disorder, and borderline personality 
disorder, age, race, and IQ. Both male and female sex has been shown to be related to higher 
chances of substance use following treatment in different contexts (Soyka & Schmidt, 2009; 
Walitzer & Dearing, 2006; Wilson, Bandyopadhyay, Yang, Cerulli, & Morse, 2018). 
Additionally, comorbid psychiatric disorders including anxiety (Schellekens, de Jong, Buitelaar, 
& Verkes, 2015), depression (Suter, Strik, & Moggi, 2011),  anti-social personality disorder 
(Goldstein et al., 2001; Sargeant, Bornovalova, Trotman, Fishman, & Lejuez, 2012), and 
borderline personality disorder (Zanarini et al., 2011) have all been shown to be related to worse 
substance use outcomes. Young age has been shown to be associated with worse substance use 
outcomes during treatment (Harrison & Asche, 1999). Better substance use outcomes for White, 
when compared to minority, individuals has also been highlighted multiple times (Chartier & 
Caetano, 2010; Greenfield et al., 2018).  
Gaps in the Literature 
There is no study to date that has examined effort-based decision making for reward in 
relation to substance use outcomes in a diverse substance-using population. The validity of the 
EEfRT construct in predicting outcomes such as treatment adherence (Mata et al., 2017), and 
reward processing deficits (such as those with schizophrenia) (McCarthy et al., 2016) highlights 
effort expenditure for reward as a potential area of focus for other populations who experience 
reward dysregulation, such as those who are suffering from SUD (Koob & Le Moal, 2001).  
Present Study 
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Individuals in SUD treatment are attempting to maintain abstinence, but the positive 
rewards associated with abstinence are uncertain. Understanding how individuals weigh both 
reward probability and reward magnitude in decision making is salient for better understanding 
of the factors associated with abstinence. Additionally, the ability to respond to reward has been 
shown to increase with abstinence (Garfield et al., 2014; Gowin et al., 2015), highlighting a need 
for understanding not only how effort-based decision making predicts return to substance use, 
but how substance use predicts effort-based decision making.  The goals of this study are 
therefore the following:  
Aim 1. To test the relationship between pre-treatment effort-based decision making and 
frequency of substance use up to a 3-month follow-up. 
Hypothesis: Individuals who more frequently choose to engage in the hard task of the  
EEfRT for low and medium chances of reward will report fewer substance use days 
between pre-treatment and a 3-month follow-up.  
Aim 2. To test the effect of substance use frequency during the follow-up period on change in 
effort expenditure for reward.  
Hypothesis: Substance use (i.e., proportion of days of substance use) will moderate the 
change in effort expenditure (i.e., engage in the hard task of the EEfRT for low and 
medium chances of reward), such that substance use will attenuate the improvement in 
effort expenditure between pre-treatment and the 3-month follow-up.   
Aim 3. Although no effects are expected, an exploratory analysis into the questions posed in 
aims 1 and 2 will be conducted with the proportion of total hard choices on the EEfRT task and 
the proportion of hard choices for high probability of reward.   
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Methods 
Participants 
Participants were recruited from an intensive outpatient treatment program in the larger 
Raleigh, North Carolina community for participation in a randomized control trial testing the 
effect of a behavioral treatment. Participants were excluded from the study if they met criteria for 
current psychosis as measured by the MINI-K (Sheehan et al., 1997), if they were over the age of 
65 or under the age of 18, if they had completed more than 6 weeks of I.O.P. treatment, or if they 
scored below a 42 on the Wide Range Achievement Test (Jastak & Wilkinson, 1984). 
Participants were included in the current study if they had complete measures from the baseline 
assessment and the three-month follow-up, which generated a final sample of 86 adults (72.1% 
male: Mage = 41.0 SD = 11.0,  range 21-62; 54.7% Non-Hispanic White, 41.9% Black/African 
American; neither Hispanic or Asian ethnicity were endorsed).  
General Procedures 
 Following initial screening, participants provided informed consent for the parent study, a 
randomized controlled trial testing the effectiveness of a behavioral treatment on substance use. 
Participants then completed the Mini International Neuropsychiatric Interview (Sheehan et al., 
1997), and provided contact information for follow-up assessments. Three days later at the 
baseline assessment, participants completed a battery of survey measures on an iPad through the 
platform Qualtrics (relevant measures discussed further below), as well as the Effort Expenditure 
for Rewards Task (Treadway et al., 2009) and the clinician administered Timeline Followback 
(Sobell & Sobell, 1992). Treatment sessions occurred for 3-weeks, and follow-up assessments 
were conducted at post treatment, 1, 3, 6, and 12 months after treatment, however this study only 
considers measures from the screening/baseline assessment and the 3-month follow-up.    
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Measures 
Participant Characteristics and Survey Measures 
 Demographic information was assessed at baseline using a questionnaire administered 
electronically on an iPad. Age (continuous), sex(male/female), race (white, African-American, 
Asian/Southeast Asian, Native American/American Indian, or other), ethnicity (Hispanic/non-
Hispanic) and education (number of years completed) were all assessed in order to collect 
information on potential covariates.  
 One additional measure was taken from the larger battery of survey measures as a 
potential covariate: the Circumstances, Motivation, and Readiness scale (CMR; De Leon, 
Melnick, Kressel, & Jainchill, 1994). This scale measures an individual’s potential to remain 
engaged in substance use treatment based on their Circumstances (exterior motivations or 
pressures to attend treatment), Motivation (intrinsic desire to change substance use habits), and 
Readiness (an individual’s perception of their own need for treatment). Participants rated 
statements on a 5-point Likert scale ranging 1=strongly disagree to 5=strongly agree. The total 
score is included as a covariate in the current study. The hypotheses of this study were built on 
the assumption that participants were attempting to achieve abstinence, which is not universally 
true of those in substance use treatment. Including the CMR as a covariate serves to control for 
the possibility that a participant was not attempting to achieve abstinence.  
Comorbid Psychopathology  
In order to assess psychiatric symptoms, the Mini International Neuropsychiatric 
Interview (MINI) (Sheehan et al., 1997) was utilized to inquire about symptoms of major 
depressive disorder, panic disorder (PD), agoraphobia, social anxiety disorder (SAD), obsessive 
compulsive disorder (OCD), post-traumatic stress-disorder (PTSD), general anxiety disorder 
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(GAD), anti-social personality disorder (ASPD), and borderline personality disorder (BPD). 
Additionally, participants were evaluated to see if they meet criteria for several substance use 
disorders, including alcohol use disorder, stimulant use disorder, cocaine use disorder, opiate use 
disorder, hallucinogen use disorder, dissociative use disorder, inhalant use disorder, cannabis use 
disorder, tranquilizer use disorder, and miscellaneous substance use disorder. For the purposes of 
these analyses, a dummy variable (1: meets criteria, 0: does not meet criteria) was generated to 
indicate if a participant met criteria for any of the aforementioned psychiatric or substance use 
disorders. The MINI has been shown to be a valid and reliable measure in comparison to the 
Structure Clinical Interview for Diagnostic and Statistical Manual (Sheehan et al., 1997), and has 
been used previously in populations with substance use disorder (Langås, Malt, & Opjordsmoen, 
2011; Magura, Rosenblum, & Betzler, 2009). 
Effort Expenditure for Rewards Task (EEfRT) 
 Willingness to expend effort for reward was assessed with the Effort Expenditure for 
Rewards Task (Treadway et al., 2009). The EEfRT is a measure of an individual’s propensity to 
expend effort for varying magnitudes of monetary reward, dependent on the probability of 
receiving said reward (Treadway et al., 2009). The 20-minute task consists of a series of 
individual trials in which participants choose between an easy or a hard task for varying 
magnitudes and probabilities of reward. The hard task involves pressing a computer key with the 
pinky of the non-dominant hand 100 times within 21 seconds, and the easy task involves 
pressing a computer key with the index finger of the dominant hand 30 times within 7 seconds. 
For the easy task, the monetary reward is always $1, while the monetary reward for the hard task 
varies between $1.20 and $4.30. Reward probability is displayed to the participant as either 12% 
(low), 50% (medium), or 88% (high). For each trial, participants are shown the probability of 
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winning and the possible compensation for the hard task for five seconds, during which time they 
are given the choice of the easy and the hard task. If a decision for the easy or hard task is not 
selected within the five seconds, the difficulty of the task is randomly chosen by the computer.  
Since participants played continuously for 20 minutes, and hard trials took longer than 
easy trials, trial number was variable. In order to standardize analyses, only the first 40 trials 
were included in analyses. Included in analyses were the total hard choices and proportion of 
hard choices for each probability of reward (low, medium, high) at baseline assessment and 3-
month follow-up. The EEfRT has been shown to have high test-retest reliability in individuals 
with cognitive deficits (Horan et al., 2015; Reddy et al., 2015). Additionally, reward sensitivity 
beta values were calculated to quantify an individual’s responsiveness to reward magnitude 
based on the probability of receiving that reward. These betas were generated by performing 
logistical regressions for each participant of the association of the expected value of the reward, 
defined as the probability of receiving the reward multiplied by the magnitude of the reward, and 
hard/easy task choice on the EEfRT (Treadway et al., 2014). Betas were excluded if they fell 
greater than two standard deviations above the mean (N=31 [15 excluded from baseline and 16 
excluded from 3-month follow-up]).  
Timeline Followback  
 Substance use during the assessment period was assessed using the clinician-administered 
Timeline Followback (TLFB) (Sobell & Sobell, 1992). Participants are asked to recount the type 
and amount of substance use for each day over an assessment period. During this study, 
participants were asked to recount information about all substances they might have used over 
the assessment period, and were specifically asked to verify if they had used any alcohol, 
marijuana, cocaine, heroin, MDMA, amphetamine, hallucinogens, methamphetamine, sedatives, 
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dissociatives, painkillers, inhalants, opiate dependency medications or any other non-prescribed 
substances during the time between baseline and the 3 month follow-up and between the baseline 
assessment and the 30 days prior to the start of intensive outpatient treatment. The TLFB has 
been used extensively in the field (Hjorthøj, Hjorthøj, & Nordentoft, 2012) and has been shown 
to have high validity and agreement with urinalysis results. Proportion of days used was 
generated by taking the total number of days used between the baseline assessment and the 3-
month follow-up and dividing it by the total number of days assessed. Additionally, in order to 
evaluate potential covariates, the proportion of days used between the baseline assessment and 
the 30 days before intensive outpatient treatment began was calculated by dividing the total 
number of days of use by the number of days assessed. Finally, information from the TLFB was 
used to calculate number of days since participants last use of any substance at the baseline 
assessment.  
Statistical Analysis 
 Analyses began by generating descriptive statistics (mean, SD, range) on age, number of 
years of education, CMR Total Score, days since last use at the baseline assessment, the 
proportion of the days used between 30 days before starting intensive outpatient treatment and 
the baseline date and between baseline and 3-month follow-up, the total hard choices and hard 
choices for low, medium, and high probability of reward on the EEfRT at both baseline and 3-
month follow-up timepoints, and reward sensitivity betas for total hard choices and hard choices 
for low, medium, and high probability of reward at baseline. Additionally, percent male, percent 
white/black/ Native American/Other, and percent met criteria for each DSM-5 comorbid 
psychiatric and substance use disorder were calculated.  
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To identify possible covariates, independent samples t-tests and correlation analyses were 
performed to assess significant predictors of baseline proportion of days used and baseline 
EEfRT total hard choices, and baseline EEfRT hard choices at low, medium, and high reward 
probability. For categorical variables (sex, race, and DSM-5 disorders) independent samples t-
tests were generated to determine if any differences existed in mean proportion of days used 
from 30-days prior to admission to outpatient treatment and the baseline assessment and total 
percent of hard choices on the EEfRT, as well as EEfRT hard choices at every probability level 
between groups. If a participant characteristic was endorsed by less than 5% of the sample (e.g. 
Obsessive Compulsive Disorder), then t-tests were not conducted due to a lack of power to detect 
differences. For continuous variables (age, years of education, days since last use at baseline, and 
proportion of days used prior to baseline, CMR Total score, and reward magnitude betas for total 
hard choices and each respective reward probability) correlations were generated with the 
proportion of days used from 30-days prior to admission to outpatient treatment and the baseline 
assessment and total percent of hard choices on the EEfRT, as well as EEfRT hard choices at 
every probability level. Variables with significant associations were included as covariates in 
subsequent hierarchical linear regression analysis for each respective outcome variable.  
 Hierarchical regression models were generated to analyze relationships between hard 
choices on the EEfRT (total, low, medium, and high probability) and future days of use up to the 
3-month follow-up for a total of four models. Identified covariates were entered into step 1 for 
all 4 models. In step 2, proportion of hard choices (total, low, medium, and high probability) 
were added into their respective models.  
 Similarly, hierarchical regression models were generated to test if substance use 
moderated the relationship between effort expenditure for reward between baseline and 3-month 
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follow-up at each probability of reward for a total of four models. In step 1, identified covariates 
were regressed on the proportion of hard choices on the EEfRT (total, low, medium, and high). 
In step 2, substance use between baseline and 3-month follow-up as well as baseline proportion 
of total, low, medium, or high probability were added into their respective models. Finally, in 
step 3, the interaction term between proportion of days used and proportion of hard choices (for 
each level of reward probability) was added to assess potential moderating factors of substance 




 Participants were majority male (72.1% male) and white (55.7% White, 41.9% Black, 
4.7% Native American, 3.5% Other). 2.3% met criteria for panic disorder, 8.1% met criteria for 
agoraphobia, 16.3% met criteria for social anxiety disorder, 4.7% met criteria for obsessive 
compulsive disorder, 8.1% met criteria for post-traumatic stress disorder, 9.3% met criteria for 
generalized anxiety disorder, 7.0% met criteria for depression, 38.4% met criteria for ASPD, 
19.8% met criteria for BPD, 65.1% met criteria for alcohol use disorder, 26.7% met criteria for 
stimulant use disorder, 60.5% met criteria for cocaine use disorder, 46.5% met criteria for opiate 
use disorder, 9.3% met criteria for hallucinogen use disorder, 4.7% met criteria for dissociative 
use disorder, 4.7% met criteria for inhalant use disorder, 39.5% met criteria for cannabis use 
disorder, 27.9% met criteria for tranquilizer use disorder, and 10.5% met criteria for 
miscellaneous substance use disorders. The average years of education was 12.1 (SD: 2.5, range: 
1-16), CMR Total Score was 72.6 (SD: 10.3, range: 34-90), days since last use at baseline was 
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62.7 (SD: 107.4, range: 0-832), and the average proportion of days used in the assessment period 
before baseline was 0.15 (SD: 0.20, range: 0.00-0.87). 
Identification of Covariates 
 Table 1 displays means, standard deviations, and ranges for all continuous IVs, DVs, and 
potential covariates. Table 2 displays mean differences and counts for all baseline categorical 
IVs, DVs, and potential covariates. Table 3 displays correlations between potential continuous 
covariates and the IVs utilized in this study. Independent sample t-tests between potential 
categorical covariates and proportion of days used at baseline assessment yielded no significant 
associations. In correlation analyses, the number of days since a participant had last used any 
substance was significantly correlated with the proportion of days used at the baseline 
assessment. Independent sample t-tests between potential categorical covariates and total hard 
choices on the EEfRT yielded significant associations with anti-social personality disorder, 
stimulant use disorder, and hallucinogen use disorder. Hard choices for low probability of reward 
was significantly associated with alcohol use disorder, stimulant use disorder, opiate use disorder 
and hallucinogen use disorder. Hard choices for medium probability of reward was significantly 
associated with anti-social personality disorder. Hard choices for high probability of reward was 
significantly associated with post-traumatic stress disorder, alcohol use disorder, and 
hallucinogen use disorder. Reward sensitivity beta was significantly associated with total hard 
choices and hard choices for low-probability of reward. Age was significantly associated with 
hard choices for reward across all reward values.  
Hierarchical Linear Regression Modeling 
 In hierarchical linear models predicting proportion of days of substance use between 
baseline and the 3-month follow-up, neither total hard choices or hard choices for any level of 
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reward probability (low, medium, or high) significantly predicted frequency of substance use  
(Table 4).  
 In moderation analyses, there were no significant interaction effects, such that the 
interaction between substance use frequency and hard choices (across all reward levels) was not 
significantly associated with hard choices at the 3-month follow-up (Tables 5-8). Across all 
reward levels, baseline hard choices was positively and significantly associated with hard 
choices at the 3-month follow-up.  
 
Discussion 
 This study utilized the effort expenditure for reward task (EEfRT) to test the association 
between pretreatment willingness to expend effort for a reward and the frequency of substance 
use during a 3-month follow-up period among adults enrolled in intensive outpatient treatment 
for substance use. Additionally, this study analyzed the relationship between performance on the 
EEfRT between baseline assessment and a 3-month follow-up assessment and analyzed potential 
moderation of substance use between these time points. The primary hypothesis was that 
choosing to put forth effort for the hard task when reward was uncertain (12% and 50% chance 
of winning) would predict substance use at follow-up. Additionally, it was hypothesized that 
substance use between baseline and 3-month follow-up would moderate the relationship between 
hard choices for uncertain reward (12% and 50%) on the EEfRT between assessments. It was 
also hypothesized that similar modeling for the previous hypotheses for total hard choices and 
hard choices for high probability of reward would yield no significant associations.  
The primary hypothesis was unsupported. No significant associations were present 
between engagement in the hard task for low and medium chances of reward and future 
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substance use. Similarly, the second hypothesis was unsupported. Substance use between 
assessments did not moderate the relationship between the EEfRT hard choices for low and 
medium probabilities of reward at baseline and follow-up. The third hypothesis was supported: 
there were no significant relationships between hard choices for high probability for reward/total 
hard choices and substance use at follow-up, nor did substance use moderate the relationship 
between either at baseline with its counterpart at 3-month follow-up. The relationship between 
EEfRT at baseline and EEfRT at follow-up was significant for total hard choices and all levels of 
reward probability (low, medium, high), providing support for test-retest reliability of the EEfRT 
in the SUD population.  
 There are many other factors related to reward that may impact an individual’s ability to 
remain abstinent. Rewards associated with substance use are immediate and positive, while 
rewards associated with abstinence are larger, but less likely to manifest in the short term. 
Impulsive decisions to use may overpower long-term effortful decision making to remain sober. 
Impulse control encompasses risky decision making, memory impairment, and delayed reward 
discounting (Brooks et al., 2017). Risky decision making (Duarte, Woods, & Rooney, 2012) and 
memory impairment (Khurana, Romber, Betancourt, & Hurt, 2017) have both been shown to be 
related to substance use disorder and are involved in decisions to use. Additionally, delayed 
reward discounting, or the extent to which an individual devalues a reward based on the length of 
time it takes to receive it has been shown to be related to the decision to use (Heil, Johnson, 
Higgins, & Bickel, 2006; Kirby & Petry, 2003; MacKillop & Kahler, 2009). In connection to 
emotional states, negative affect-driven impulsivity, conceptualized as the urgency to alleviate 
negative emotional states, has been shown to be significantly related to problems associated with 
substance use disorder (Verdejo-García, Bechara, Recknor, & Pérez-García, 2007). While the 
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EEfRT does measure how individuals value reward based on probability and magnitude when 
making effortful decisions (Treadway et al., 2009), it is possible that it is not mapping on to the 
decision making involved in an abstinence attempt, as it does not capture the negative affect that 
may drive impulsive decisions to use.  
Abstinence attempts are associated with high levels of physical and psychological 
distress (U.S. Department of Health and Human Services, 2016) and the negative sensations 
associated with withdraw serve as powerful drives to use (Koob & Le Moal, 2001). The ability to 
withstand psychological distress has been shown to be associated with abstinence duration 
(Daughters, Lejuez, Kahler, Strong, & Brown, 2005). It is possible that distress tolerance, or the 
ability of an individual to endure aversive physical, psychological, and emotional states (Brown, 
Lejuez, Kahler, Strong, & Zvolensky, 2005), could tie in to effortful decision making. The 
tendency to act impulsively as related to distress has been shown to be related to substance use 
and consequences associated with substance use (Kaiser, Milich, Lynam, & Charnigo, 2012). 
Additionally, low, but not high, levels of distress tolerance have been shown to significantly 
interact with negative affect in predicting alcohol use (Gorka, Ali, & Daughters, 2012). It is 
possible that effortful decision making is impacted by distress tolerance, such that individuals 
with high distress tolerance are more able to exert effort for uncertain reward, while those with 
lower distress tolerance are unable to do so.  
Limitations and Future Directions 
The sample contained an unusual group make-up in terms of psychiatric comorbidity. It is 
estimated that 32.8% of Individuals in treatment for alcohol use disorder and 44.3% of 
individuals in treatment for a drug use disorder struggle with comorbid depression (Grant et al., 
2006). The low levels of depression (around 7% of our sample) were unusual. Since major 
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depressive disorder is related to anhedonia (Keedwell, Andrew, Williams, Brammer, & Phillips, 
2005), the main construct the measure is measuring (Treadway et al., 2009), it is possible that 
relationships between the EEfRT and substance use exist among individuals with psychiatric 
comorbidities associated with anhedonia, but there was not a large enough sample size of these 
individuals to distinguish differences.  
 The lack of significant relationships in this study raises questions about how effortful 
decision making is related to substance use or consequences associated with substance use 
disorder. Future studies may explore if effortful decision making, as related to affective and 
physical states more closely related to an abstinence attempt are related to consequences 
associated with substance use disorder. For example, a modified version of the EEfRT that 
involved effortful decision making with a physically or psychologically distressing task could 
better capture how effortful decision making, in combination with distress tolerance, might be 
associated with substance use outcomes.  
Another possible direction for future research could be to investigate the relationship 
between the EEfRT between individuals with substance use disorder and healthy controls. While 
substance use was not predicted by within group differences on the EEfRT, it is possible that 
effortful decision making is dysregulated between those who develop SUD and healthy controls.  
Finally, in t-tests there were several significant differences in EEfRT behavior based on 
drug of choice, which could be further evaluated in future studies.  
 Despite limitations, this study provides a novel examination of the relationship between 
substance use and effortful decision making, and extends the literature of the links between 
reward processing and substance use disorder.  
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Tables 
Table 1. Distribution of IV, DV, and potential Covariate Continuous Variables (N=86) 
Characteristics Mean SD Range 
Baseline    
Proportion of hard choices    
Total 0.41 0.26 0.00-1.00 
low probability 0.40 0.28 0.00-1.00 
medium probability 0.45 0.29 0.00-1.00 
high probability 0.38 0.27 0.00-1.00 
Reward Magnitude Betas    
Total 0.38 0.73 -1.46- 2.56 
low probability 0.20 1.55 -3.31-4.41 
medium probability 0.57 1.19 -1.49-6.06 
high probability 0.50 1.75 -6.92-6.08 
Proportion of days used 0.15 0.20 0.00-0.87 
Age 40.99 11.02 21.00-62.00 
Years of Education 12.10 2.47              1.00-16.00 
CMR Total Score 72.57 10.30 34.00-90.00 
Days Since Last Use 62.66 107.42 0.00-832.00 
3-month follow-up    
Proportion of hard choices    
Total 0.38 0.30 0.00-1.00 
low probability 0.35 0.30 0.00-1.00 
medium probability 0.41 0.32 0.00-1.00 
high probability 0.37 0.31 0.00-1.00 
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Table 2. T-test comparisons of proportion of days used at baseline and total percent of 
EEfRT hard choices by sociodemographic/MINI diagnostic criteria (N=86) 
 
 Mean (SD) 
 Substance 
Use Days Proportion of Hard Choices 
 
 Total Low Medium High 
Sex      
Female (N=24) 0.18 (0.24) 0.38 (0.26) 0.34 (0.26) 0.44 (0.30) 0.35 (0.26) 
Male (N=62) 0.14 (0.18) 0.42 (0.27) 0.42 (0.28) 0.45 (0.29) 0.39 (0.28) 
White      
No (N=39) 0.18 (0.24) 0.42 (0.28) 0.40 (0.30) 0.46 (0.30) 0.38 (0.29) 
Yes (N=47) 0.13 (0.15) 0.40 (0.25) 0.39 (0.27) 0.44 (0.29) 0.38 (0.26) 
Black      
No (N=50) 0.15 (0.20) 0.42 (0.25) 0.41 (0.27) 0.46 (0.29) 0.40 (0.26) 
Yes (N=36) 0.16 (0.20) 0.39 (0.28) 0.38 (0.30) 0.43 (0.30) 0.36 (0.29) 
PD + 
Agoraphobia      
No (N=75) 0.15 (0.20) 0.39 (0.25) 0.37 (0.27) 0.43 (0.28) 0.36 (0.26) 
Yes (N=7) 0.18 (0.24) 0.54 (0.29) 0.57 (0.30) 0.54 (0.34) 0.52 (0.30) 
PTSD      
No (N=75) 0.15 (0.20) 0.39 (0.25) 0.37 (0.27) 0.44 (0.29) 0.35 (0.25)* 
Yes (N=7) 0.23 (0.21) 0.55 (0.30) 0.54 (0.34) 0.50 (0.30) 0.60 (0.30) 
GAD      
No (N=74) 0.16 (0.20) 0.41 (0.26) 0.40 (0.28) 0.45 (0.29) 0.38 (0.27) 
Yes (N=8) 0.13 (0.13) 0.32 (0.25) 0.32 (0.26) 0.35 (0.29) 0.28 (0.25) 
SAD      
No (N=68) 0.14 (0.19) 0.39 (0.26) 0.38 (0.28) 0.43 (0.29) 0.37 (0.27) 
Yes (N=14) 0.23 (0.24) 0.45 (0.26) 0.45 (0.27) 0.49 (0.30) 0.40 (0.26) 
MDD      
No (N=76) 0.15 (0.19) 0.40 (0.26) 0.39 (0.28) 0.44 (0.29) 0.36 (0.27) 
Yes (N=6) 0.15 (0.26) 0.46 (0.25) 0.42 (0.31) 0.49 (0.29) 0.46 (0.23) 
ASPD      
No (N=49) 0.15 (0.22) 0.35(0.25)* 0.34 (0.26) 0.38 (0.29)* 0.33 (0.26) 
Yes (N=33) 0.16 (0.17) 0.47(0.26) 0.46 (0.29) 0.53 (0.28) 0.43 (0.27) 
BPD      
No (N=65) 0.15 (0.21) 0.38 (0.25) 0.36 (0.26) 0.41 (0.27) 0.35 (0.25) 
Yes (N=17) 0.16 (0.14) 0.50 (0.29) 0.48 (0.30) 0.55 (0.33) 0.46 (0.29) 
Alcohol UD      
No (N=26) 0.17 (0.24) 0.48 (0.26) 0.48 (0.27)* 0.49 (0.30) 0.46 (0.27)* 
Yes (N=56) 0.14 (0.17) 0.36 (0.25) 0.34 (0.27) 0.42 (0.28)  0.33 (0.25) 
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Stimulant UD      
No (N=59) 0.15 (0.21) 0.36 (0.25)* 0.34 (0.27)** 0.41 (0.28) 0.34 (0.24) 
Yes (N=23) 0.16 (0.16) 0.50 (0.27) 0.51 (0.26) 0.52 (0.29)   0.45 (0.31) 
Cocaine UD      
No (N=30) 0.17 (0.23) 0.35 (0.21) 0.33 (0.22) 0.40 (0.26) 0.32 (0.20) 
Yes (N=52) 0.14 (0.18) 0.43 (0.28) 0.42 (0.30) 0.47 (0.30) 0.40 (0.29) 
Opiate UD      
No (N=42) 0.14 (0.18) 0.35 (0.24) 0.33 (0.25)* 0.40 (0.26) 0.33 (0.25) 
Yes (N=40) 0.17 (0.22) 0.45 (0.28) 0.45 (0.29) 0.49 (0.31) 0.42 (0.28) 
Hallucinogen UD      
No (N=74) 0.16 (0.20) 0.38 (0.26)* 0.37 (0.27)* 0.42 (0.29) 0.35 (0.26)* 
Yes (N=8) 0.11 (0.16) 0.58 (0.21) 0.59 (0.23) 0.60 (0.24)  0.55 (0.24) 
Cannabis UD      
No (N=48) 0.15 (0.22) 0.37 (0.24) 0.35 (0.26) 0.40 (0.27) 0.35 (0.24) 
Yes (N=34) 0.15 (0.17) 0.45 (0.28) 0.44 (0.29) 0.50 (0.30) 0.41 (0.30) 
Tranquilizer UD      
No (N=58) 0.17 (0.22) 0.38 (0.25) 0.37 (0.27) 0.42 (0.28) 0.35 (0.25) 
Yes (N=24) 0.12 (0.14) 0.45 (0.28) 0.44 (0.28) 0.49 (0.31) 0.43 (0.29) 
Misc. UD      
No (N=73) 0.15 (0.21) 0.39 (0.25) 0.38 (0.26) 0.44 (0.29) 0.36 (0.25) 
Yes (N=9) 0.14 (0.14) 0.46 (0.34) 0.45 (0.36) 0.46 (0.33) 0.48 (0.37) 
PD: panic disorder, PTSD: post-traumatic stress disorder, GAD: generalized anxiety disorder, 
SAD: social anxiety disorder, MDD: major depressive disorder, ASPD: anti-social personality 
disorder, BPD: borderline personality disorder, UD: use disorder 
Substance Use Days: Proportion of days used between 30 days prior to admission to intensive 
outpatient treatment and baseline assessment 
Proportion of Hard Choices:  Proportion of hard choices for total EEfRT task, and for trials 
with low (12%) probability of reward, medium (50%) probability of reward, and high (88%) 
probability of reward 
*p<0.05; **p<0.01           
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Table 3. Correlation of proportion of days used at baseline and total percent of EEfRT 
hard choices with participant self-report measures and EEfRT Reward Betas (N=86) 
 Substance 
Use Days Hard Choices 
  Total Low Medium High 
Age -0.120 -0.280** -0.305** -0.260* -0.232* 
Years of Education 0.047 0.003 0.026 0.030 -0.046 
Days since last use at baseline -0.337** 0.052 0.078 0.066 0.004 
Proportion of days used prior to baseline 1.000** -0.070 -0.042 -0.060 -0.093 
CMR Total Score 0.035 -0.046 0.015 -0.033 -0.105 
Reward Sensitivity Betas      
Total Hard Choices -0.043 0.236* 0.197 0.170 -0.301** 
Hard Choices for High Probability of Reward 0.020 -0.062 -0.063 -0.086 -0.026 
Hard Choices for Medium Probability of Reward 0.153 0.202 0.195 0.183 0.191 
Hard Choices for Low Probability of Reward 0.106 0.242* 0.275* 0.171 0.249* 
CMR: Circumstances, Motivation, & Readiness      
*p<0.05; **p<0.01      
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Table 4. Relationship between EEfRT hard choices (total, high probability, medium 
probability, and low probability) and proportion of substance use days at 3-month follow-
up (N=85) 
 
   ΔR2 ΔF   P value of ΔF   B (SE) 95% CI 
Step 1 (all models).   0.034 2.942 0.090   
 Days Since Last Use    0.000 (0.000) (-0.001-0.000) 
Total Hard Choices: R2= 0.035, F(2,83)=1.511, p=0.227  
Step 2.  0.001 0.111 0.740   
 Days Since Last Use    0.000 (0.000) (-0.001-0.000) 
  Total Hard Choices    0.033 (0.099) (-0.164-0.230) 
Hard Choices for high probability of reward: R2= 0.034, F(2,83)=1.474, p=0.235 
Step 2.  0.000 0.040     0.842   
 Days Since Last Use    0.000 (0.000) (-0.001-0.000) 
  Hard choices for high probability    0.019 (0.097) (-0.173-0.211) 
Hard Choices for medium probability of reward:  R2= 0.034, F(2,83)=1.454, p=0.240 
Step 2.  0.000 0.001     0.980   
 Days Since Last Use    0.000 (0.000) (-0.001-0.000) 
  Hard choices for medium probability    -0.002(0.090) (-0.182-0.178) 
Hard Choices for low probability of reward: R2= 0.042, F(2,83)=1.837, p=0.166 
Step 2.  0.009 0.740     0.392   
 Days Since Last Use    0.000 (0.000) (-0.001-0.000) 
  Hard choices for low probability    0.080 (0.093) (-0.105-0.266) 
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Table 5. Relationship between Baseline total hard choices during EEfRT and substance use 
predicting EEfRT total hard choices at 3-month follow-up (N=78) 
   R2=0.516, F(8,70)=9.322, p<0.001 ΔR2 ΔF   
P 
value 
of ΔF   
B (SE) 95% CI 
Step 1.  0.149 2.553 0.035   
 Age    -0.001 (0.003) (-0.008-0.655) 
 ASPD    0.077 (0.065) (-0.052-0.205) 
 Stimulant UD    -0.032 (0.083) (-0.197-0.133) 
 Hallucinogen UD    0.089 (0.125) (-0.161-0.339) 
 Reward Sensitivity Beta*    0.117 (0.045) (0.027-0.207) 
Step 2.  0.364 26.545 0.000   
 Age    0.001 (0.003) (-0.004-0.007) 
 ASPD    0.030 (0.050) (-0.070-0.130) 
 Stimulant UD    -0.074 (0.064) (-0.202-0.054) 
 Hallucinogen UD    0.085 (0.096) (-0.107-0.276) 
 Reward Sensitivity Beta    0.068 (0.036) (-0.003-0.139) 
 Percent of Days Used    0.081 (0.119) (-0.156-0.317) 
 Total Hard Choices at baseline**    0.733 (0.101) (0.533-0.934) 
Step 3.   0.003 0.411 0.523   
 Age    0.001 (0.003) (-0.004-0.007) 
 ASPD    0.032 (0.050) (-0.069-0.132) 
 Stimulant UD    -0.070 (0.065) (-0.199-0.059) 
 Hallucinogen UD    0.079 (0.097) (-0.114-0.273) 
 Reward Sensitivity Beta    0.067 (0.036) (-0.004-0.139) 
 Percent of Days Used    -0.002 (0.175) (-0.351-0.348) 
 Total Hard Choices at baseline**    0.701 (0.113) (0.477-0.926) 
  Percent of Days Used X Total Hard Choices    0.252 (0.393) (-0.531-1.035) 
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Table 6. Relationship between Baseline hard choices for high probability of reward during 
EEfRT and substance use predicting EEfRT hard choices for high probability of reward at 
3-month follow-up (N=81) 
   R2=0.517, F(7,74)=11.307, p<0.001 ΔR2 ΔF   
P 
value 
of ΔF   
B (SE) 95% CI 
Step 1.  0.099 2.120 0.086   
 Age    -0.003 (0.003) (-0.009-0.003) 
 PTSD    0.125 (0.118) (-0.110-0.361) 
 Alcohol UD    -0.079 (0.071) (-0.220-0.061) 
 Hallucinogen UD    0.160 (0.120) (-0.078-0.398) 
Step 2.  0.416 32.130 0.000   
 Age    -0.001 (0.002) (-0.006-0.003) 
 PTSD    -0.015 (0.090) (-0.195-0.165) 
 Alcohol UD    0.010 (0.054) (-0.098-0.117) 
 Hallucinogen UD    0.045 (0.090) (-0.135-0.224) 
 Percent of Days Used    -0.024 (0.107) (-0.238-0.189) 
 Total high probability hard choices at baseline**   0.784 (0.099) (0.586-0.981) 
Step 3.   0.002 0.298 0.587   
 Age    -0.002 (0.002) (-0.006-0.003) 
 PTSD    0.003 (0.096) (-0.189-0.195) 
 Alcohol UD    0.011 (0.054) (-0.098-0.119) 
 Hallucinogen UD    0.038 (0.091) (-0.144-0.220) 
 Percent of Days Used    -0.104 (0.181) (-0.465-0.257) 
 Total high probability hard choices at baseline**   0.754 (0.113) (0.528-0.980) 
  Percent of Days Used X Hard Choices for high probability 0.233 (0.427) (-0.617-1.083) 
*p<0.05; **p<0.01      
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Table 7. Relationship between Baseline hard choices for medium probability of reward 
during EEfRT and substance use predicting EEfRT hard choices for medium probability 
of reward at 3-month follow-up (N=81) 
 
   R2=0.410, F(5,76)=10.560, p<0.001 ΔR2 ΔF   
P 
value 
of ΔF   
B (SE) 95% CI 
Step 1.  0.082 3.522 0.034   
 Age    -0.005 (0.003) (-0.011-0.001) 
 ASPD    0.132 (0.069) (-0.006-0.271) 
Step 2.  0.326 21.217 0.000   
 Age    -0.001 (0.003) (-0.007-0.004) 
 ASPD    0.047 (0.058) (-0.068-0.162) 
 Percent of Days Used    -0.004 (0.123) (-0.249-0.240) 
 Total medium probability hard choices at baseline**   0.660 (0.102) (0.457-0.863) 
Step 3.   0.002 0.240 0.626   
 Age    -0.002 (0.003) (-0.007-0.004) 
 ASPD    0.049 (0.058) (-0.067-0.166) 
 Percent of Days Used    -0.083 (0.203) (-0.488-0.321) 
 Total medium probability hard choices at baseline**   0.635 (0.115) (0.406-0.864) 
  Percent of Days Used X Hard Choices for medium probability   0.199 (0.406) (-0.610-1.007) 
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Table 8. Relationship between Baseline hard choices for low probability of reward during 
EEfRT and substance use predicting EEfRT hard choices for low probability of reward at 
3-month follow-up (N=78) 
   R2=0.431, F(9.69)=5.816, p<0.001 ΔR2 ΔF   
P 
value 
of ΔF   
B (SE) 95% CI 
Step 1.  0.107 1.443 0.210   
 Age    -0.001 (0.004) (-0.009-0.006) 
 Alcohol UD    -0.084 (0.076) (-0.236-0.068) 
 Stimulant UD    -0.052 (0.087) (-0.227-0.122) 
 Opiate UD    -0.066 (0.083) (-0.231-0.100) 
 Hallucinogen UD*    0.288 (0.125) (0.039-0.538) 
 Reward Sensitivity Beta    0.030 (0.022) (-0.014-0.075) 
Step 2.  0.324 19.946 0.000   
 Age    0.001 (0.003) (-0.005-0.007) 
 Alcohol UD    0.006 (0.063) (-0.120-0.132) 
 Stimulant UD    -0.108 (0.072) (-0.251-0.035) 
 Opiate UD    -0.032 (0.068) (-0.167-0.103) 
 Hallucinogen UD    0.177 (0.103) (-0.028-0.382) 
 Reward Sensitivity Beta    0.000 (0.019) (-0.037-0.037) 
 Percent of Days Used    -0.029 (0.131) (-0.290-0.232) 
 Total low probability hard choices at baseline**   0.695 (0.110) (0.475-0.915) 
Step 3.   0.000 0.000 0.987   
 Age    0.001 (0.003) (-0.005-0.007) 
 Alcohol UD    0.006 (0.064) (-0.122-0.134) 
 Stimulant UD    -0.108 (0.073) (-0.253-0.037) 
 Opiate UD    -0.032 (0.069) (-0.170-0.106) 
 Hallucinogen UD    0.177 (0.104) (-0.030-0.384) 
 Reward Sensitivity Beta    0.000 (0.019) (-0.038-0.038) 
 Percent of Days Used    -0.031 (0.196) (-0.423-0.360) 
 Total low probability hard choices at baseline**   0.694 (0.125) (0.444-0.944) 
  Percent of Days Used X Hard Choices for low probability   0.007 (0.433) (-0.857-0.871) 
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